Showing results (501-510 of 683) with videos related to

Sort By:
Pageof 69
Free Radical Biology & Medicine|December 24, 2016
5,6-δ-DHTL, a stable metabolite of arachidonic acid, is a potential EDHF that mediates microvascular dilationReut Levi-Rosenzvig, Andreas M Beyer, Joseph Hockenberry, et al.
BMC Public Health|June 21, 2023
Areas of enduring COVID-19 prevalence: drivers of prevalence and mitigating strategiesCatherine Lewis, Sheena Johnson, Angelique Hartwig, et al.
International Journal of Clinical Pharmacy|February 15, 2025
Pharmacy-led interventions to reverse and prevent prescribing cascades in primary care: a proof-of-concept studyAtiya K Mohammad, Jacqueline G Hugtenburg, Yildiz Ceylan, et al.
Journal of Nanobiotechnology|February 6, 2021
Anti-bacterial and wound healing-promoting effects of zinc ferrite nanoparticlesReihaneh Haghniaz, Atiya Rabbani, Fereshteh Vajhadin, et al.
International Journal of Biological Macromolecules|March 4, 2023
Inhibition of microtubule affinity regulating kinase 4 by an acetylcholinesterase inhibitor, Huperzine A: Computational and experimental approachesMohammed Alrouji, Debarati DasGupta, Ghulam Md Ashraf, et al.
Nanoscale|July 7, 2012
Anion-controlled morphologies and spectral features of cyanine-based nanoGUMBOS--an improved photosensitizerAtiya N Jordan, Susmita Das, Noureen Siraj, et al.
Journal of the American Academy of Dermatology|July 12, 2021
Comparison of two-year treatment adherence, persistence, discontinuation, reinitiation, and switching between psoriasis patients treated with ixekizumab or secukinumab in real-world settingsAndrew Blauvelt, Nianwen Shi, Najwa Somani, et al.
Journal of Palliative Medicine|January 8, 2019
Statewide Differences in Personality Associated with Geographic Disparities in Access to Palliative Care: Findings on OpennessMichael Hoerger, Laura M Perry, Brittany D Korotkin, et al.
Dermatology and Therapy|October 15, 2021
Comparison of Real-World Treatment Patterns Among Biologic-Experienced Patients with Psoriasis Treated with Ixekizumab or Secukinumab Over 18 MonthsAndrew Blauvelt, Nianwen Shi, Russel Burge, et al.
Nanoscale|September 22, 2025
Mechanistic insights into the synergistic antimicrobial activity of nanodelivered sodium polysulfide as a sustainable strategy to combat <i>Xanthomonas</i> pathogensJorge Pereira, Edwin Davidson, Melissa M Deinys, et al.
Pageof 69